Cargando…

DNA methylation in PRDM8 is indicative for dyskeratosis congenita

Dyskeratosis congenita (DKC) is associated with impaired telomere maintenance and with clinical features of premature aging. In this study, we analysed global DNA methylation (DNAm) profiles of DKC patients. Age-associated DNAm changes were not generally accelerated in DKC, but there were significan...

Descripción completa

Detalles Bibliográficos
Autores principales: Weidner, Carola I., Lin, Qiong, Birkhofer, Carina, Gerstenmaier, Uwe, Kaifie, Andrea, Kirschner, Martin, Bruns, Heiko, Balabanov, Stefan, Trummer, Arne, Stockklausner, Clemens, Höchsmann, Britta, Schrezenmeier, Hubert, Wlodarski, Marcin, Panse, Jens, Brümmendorf, Tim H., Beier, Fabian, Wagner, Wolfgang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4905437/
https://www.ncbi.nlm.nih.gov/pubmed/26909595
http://dx.doi.org/10.18632/oncotarget.7458
_version_ 1782437259595743232
author Weidner, Carola I.
Lin, Qiong
Birkhofer, Carina
Gerstenmaier, Uwe
Kaifie, Andrea
Kirschner, Martin
Bruns, Heiko
Balabanov, Stefan
Trummer, Arne
Stockklausner, Clemens
Höchsmann, Britta
Schrezenmeier, Hubert
Wlodarski, Marcin
Panse, Jens
Brümmendorf, Tim H.
Beier, Fabian
Wagner, Wolfgang
author_facet Weidner, Carola I.
Lin, Qiong
Birkhofer, Carina
Gerstenmaier, Uwe
Kaifie, Andrea
Kirschner, Martin
Bruns, Heiko
Balabanov, Stefan
Trummer, Arne
Stockklausner, Clemens
Höchsmann, Britta
Schrezenmeier, Hubert
Wlodarski, Marcin
Panse, Jens
Brümmendorf, Tim H.
Beier, Fabian
Wagner, Wolfgang
author_sort Weidner, Carola I.
collection PubMed
description Dyskeratosis congenita (DKC) is associated with impaired telomere maintenance and with clinical features of premature aging. In this study, we analysed global DNA methylation (DNAm) profiles of DKC patients. Age-associated DNAm changes were not generally accelerated in DKC, but there were significant differences to DNAm patterns of healthy controls, particularly in CpG sites related to an internal promoter region of PR domain containing 8 (PRDM8). Notably, the same genomic region was also hypermethylated in aplastic anemia (AA) – another bone marrow failure syndrome. Site-specific analysis of DNAm level in PRDM8 with pyrosequencing and MassARRAY validated aberrant hypermethylation in 11 DKC patients and 27 AA patients. Telomere length, measured by flow-FISH, did not directly correlate with DNAm in PRDM8. Therefore the two methods may be complementary to also identify patients with still normal telomere length. In conclusion, blood of DKC patients reveals aberrant DNAm patterns, albeit age-associated DNAm patterns are not generally accelerated. Aberrant hypermethylation is particularly observed in PRDM8 and this may support identification and classification of bone marrow failure syndromes.
format Online
Article
Text
id pubmed-4905437
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-49054372016-06-24 DNA methylation in PRDM8 is indicative for dyskeratosis congenita Weidner, Carola I. Lin, Qiong Birkhofer, Carina Gerstenmaier, Uwe Kaifie, Andrea Kirschner, Martin Bruns, Heiko Balabanov, Stefan Trummer, Arne Stockklausner, Clemens Höchsmann, Britta Schrezenmeier, Hubert Wlodarski, Marcin Panse, Jens Brümmendorf, Tim H. Beier, Fabian Wagner, Wolfgang Oncotarget Research Paper: Gerotarget (Focus on Aging) Dyskeratosis congenita (DKC) is associated with impaired telomere maintenance and with clinical features of premature aging. In this study, we analysed global DNA methylation (DNAm) profiles of DKC patients. Age-associated DNAm changes were not generally accelerated in DKC, but there were significant differences to DNAm patterns of healthy controls, particularly in CpG sites related to an internal promoter region of PR domain containing 8 (PRDM8). Notably, the same genomic region was also hypermethylated in aplastic anemia (AA) – another bone marrow failure syndrome. Site-specific analysis of DNAm level in PRDM8 with pyrosequencing and MassARRAY validated aberrant hypermethylation in 11 DKC patients and 27 AA patients. Telomere length, measured by flow-FISH, did not directly correlate with DNAm in PRDM8. Therefore the two methods may be complementary to also identify patients with still normal telomere length. In conclusion, blood of DKC patients reveals aberrant DNAm patterns, albeit age-associated DNAm patterns are not generally accelerated. Aberrant hypermethylation is particularly observed in PRDM8 and this may support identification and classification of bone marrow failure syndromes. Impact Journals LLC 2016-02-17 /pmc/articles/PMC4905437/ /pubmed/26909595 http://dx.doi.org/10.18632/oncotarget.7458 Text en Copyright: © 2016 Weidner et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Paper: Gerotarget (Focus on Aging)
Weidner, Carola I.
Lin, Qiong
Birkhofer, Carina
Gerstenmaier, Uwe
Kaifie, Andrea
Kirschner, Martin
Bruns, Heiko
Balabanov, Stefan
Trummer, Arne
Stockklausner, Clemens
Höchsmann, Britta
Schrezenmeier, Hubert
Wlodarski, Marcin
Panse, Jens
Brümmendorf, Tim H.
Beier, Fabian
Wagner, Wolfgang
DNA methylation in PRDM8 is indicative for dyskeratosis congenita
title DNA methylation in PRDM8 is indicative for dyskeratosis congenita
title_full DNA methylation in PRDM8 is indicative for dyskeratosis congenita
title_fullStr DNA methylation in PRDM8 is indicative for dyskeratosis congenita
title_full_unstemmed DNA methylation in PRDM8 is indicative for dyskeratosis congenita
title_short DNA methylation in PRDM8 is indicative for dyskeratosis congenita
title_sort dna methylation in prdm8 is indicative for dyskeratosis congenita
topic Research Paper: Gerotarget (Focus on Aging)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4905437/
https://www.ncbi.nlm.nih.gov/pubmed/26909595
http://dx.doi.org/10.18632/oncotarget.7458
work_keys_str_mv AT weidnercarolai dnamethylationinprdm8isindicativefordyskeratosiscongenita
AT linqiong dnamethylationinprdm8isindicativefordyskeratosiscongenita
AT birkhofercarina dnamethylationinprdm8isindicativefordyskeratosiscongenita
AT gerstenmaieruwe dnamethylationinprdm8isindicativefordyskeratosiscongenita
AT kaifieandrea dnamethylationinprdm8isindicativefordyskeratosiscongenita
AT kirschnermartin dnamethylationinprdm8isindicativefordyskeratosiscongenita
AT brunsheiko dnamethylationinprdm8isindicativefordyskeratosiscongenita
AT balabanovstefan dnamethylationinprdm8isindicativefordyskeratosiscongenita
AT trummerarne dnamethylationinprdm8isindicativefordyskeratosiscongenita
AT stockklausnerclemens dnamethylationinprdm8isindicativefordyskeratosiscongenita
AT hochsmannbritta dnamethylationinprdm8isindicativefordyskeratosiscongenita
AT schrezenmeierhubert dnamethylationinprdm8isindicativefordyskeratosiscongenita
AT wlodarskimarcin dnamethylationinprdm8isindicativefordyskeratosiscongenita
AT pansejens dnamethylationinprdm8isindicativefordyskeratosiscongenita
AT brummendorftimh dnamethylationinprdm8isindicativefordyskeratosiscongenita
AT beierfabian dnamethylationinprdm8isindicativefordyskeratosiscongenita
AT wagnerwolfgang dnamethylationinprdm8isindicativefordyskeratosiscongenita